📉 The Financial Deep Dive
The Numbers:
Nitta Gelatin India Limited announced its un-audited financial results for the quarter and nine months ended December 31, 2025. The company demonstrated a stark divergence between its standalone and consolidated performance.
Standalone Performance:
- Q3 FY26 Revenue: ₹149.72 Cr, up 11.19% YoY.
- Q3 FY26 Profit Before Tax (PBT): ₹405.83 Cr, up 25.58% YoY.
- Q3 FY26 Profit After Tax (PAT): ₹310.61 Cr, up 27.99% YoY.
- Q3 FY26 Earnings Per Share (EPS): ₹34.21, up from ₹26.73 YoY.
- Nine Months FY26 Revenue: ₹426.57 Cr, up 7.09% YoY.
- Nine Months FY26 PAT: ₹765.82 Cr, up 21.49% YoY.
- Nine Months FY26 EPS: ₹84.35.
Consolidated Performance:
- Q3 FY26 Revenue: ₹149.72 Cr, up 11.19% YoY (same as standalone).
- Q3 FY26 Consolidated PBT: ₹351.33 Cr, up 7.27% YoY.
- Q3 FY26 Consolidated PAT: ₹256.11 Cr, up 3.85% YoY.
- Nine Months FY26 Revenue: ₹426.57 Cr, up 7.33% YoY.
- Nine Months FY26 Consolidated PAT: ₹641.54 Cr, down 1.57% YoY.
The Quality:
The standalone business exhibits healthy profitability growth outpacing revenue expansion. However, consolidated PAT growth is significantly muted, especially for the nine-month period, indicating pressure from non-operational or subsidiary-level factors. Cash flow dynamics are not detailed in this release.
The Grill:
While no explicit analyst grill is detailed, the financial results highlight a significant operational issue with a subsidiary. The announcement does not contain any forward-looking guidance or outlook from management, which is a notable absence for investors seeking directional clarity.
Discontinued Operations & Exceptional Items:
The consolidated figures are heavily impacted by the permanent closure of the subsidiary, Bamni Proteins Limited, due to persistent pollution control norm issues. Its manufacturing unit is non-operational, and its assets are classified as 'assets held for sale'. The prior year's results (Q3 FY25 and nine months ended Dec 31, 2024) included an exceptional gain of ₹668.41 Lakhs from the sale of a seafood processing facility.
Contingencies:
The company faces a contingent liability of ₹1,819.66 Lakhs related to a customs duty dispute pending a Supreme Court hearing, with a provision of ₹148.70 Lakhs already made. An incremental liability of ₹226.33 Lakhs has also been accounted for due to new labour code implementations.
🚩 Risks & Outlook
Specific Risks:
- Execution Risk: Managing the fallout and asset disposal of the discontinued subsidiary, Bamni Proteins Limited.
- Regulatory Risk: Ongoing adherence to pollution control norms and potential future environmental liabilities.
- Legal Risk: The outcome of the Supreme Court hearing regarding the customs duty dispute.
- Lack of Guidance: The absence of management outlook leaves investors with uncertainty regarding future performance drivers and targets.
The Forward View:
Investors should closely monitor developments regarding the customs duty dispute and the eventual resolution or write-off of assets related to Bamni Proteins Limited. The focus will likely remain on the performance and margin expansion within the core standalone Nitta Gelatin business, given the lack of consolidated growth drivers presently.